Netherlands Healthcare Equipment & Supplies

ONWARD Medical NV (ONWD)

Track

Track

ONWARD Medical NV experienced nine insider trading transactions over the past ninety days, all involving sales by CEO D.L. Marver. These divestments totaled approximately 251,148 EUR. The stock currently trades near its fifty-two-week low, following the most recent September 2026 results financiers report.
Ticker: ONWD Exchange: BRU
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for ONWARD Medical NV. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.3
D.L. Marver Director or Supervisory Board Member
Transaction date
Sale
Price
151.40
Quantity 54,207
Value €354,628
Marver D.L. CEO
Transaction date
Sale
Price
339.76
Quantity 64,509
Value €4,776,588
3.3
D.L. Marver Director or Supervisory Board Member
Transaction date
Sale
Price
265.11
Quantity 92,980
Value €3,048,761
Marver D.L. CEO
Transaction date
Sale
Price
2.45
Quantity 4,436
Value €10,868
3.3
D.L. Marver Director or Supervisory Board Member
Transaction date
Sale
Price
2.45
Quantity 9,080
Value €22,246
Marver D.L. CEO
Transaction date
Sale
Price
2.45
Quantity 2,845
Value €6,970
3.3
D.L. Marver Director or Supervisory Board Member
Transaction date
Sale
Price
2.45
Quantity 15,188
Value €37,211
Marver D.L. CEO
Transaction date
Sale
Price
2.46
Quantity 847
Value €2,084
3.3
D.L. Marver Director or Supervisory Board Member
Transaction date
Sale
Price
2.46
Quantity 4,645
Value €11,427
3.3
Marver, Lawrence CEO
Transaction date
Sale
Price
3.27
Quantity 152,759
Value €499,522
I. Curtis Director or Supervisory Board Member
Transaction date
Purchase
Price
4.50
Quantity 111,089
Value €499,900
K.M. Dziekan Director or Supervisory Board Member
Transaction date
Purchase
Price
4.50
Quantity 22,222
Value €99,999
G.R. Courtine Director or Supervisory Board Member
Transaction date
Purchase
Price
4.50
Quantity 22,222
Value €99,999
F.A. Colen Director or Supervisory Board Member
Transaction date
Purchase
Price
4.50
Quantity 22,222
Value €99,999
D.L. Marver Director or Supervisory Board Member
Transaction date
Purchase
Price
4.50
Quantity 33,245
Value €149,602
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-31 2026-08-28 S Sale
3.3
D.L. Marver
Director or Supervisory Board Member
54,207
151.40
€354,628 		54,207 151.40 €354,628
2026-08-17 2026-08-11 S Sale
Marver D.L.

CEO
64,509
339.76
€4,776,588 		64,509 339.76 €4,776,588
2026-08-13 2026-08-11 S Sale
3.3
D.L. Marver
Director or Supervisory Board Member
92,980
265.11
€3,048,761 		92,980 265.11 €3,048,761
2026-08-11 2026-08-07 S Sale
Marver D.L.

CEO
4,436
2.45
€10,868 		4,436 2.45 €10,868
2026-08-10 2026-08-07 S Sale
3.3
D.L. Marver
Director or Supervisory Board Member
9,080
2.45
€22,246 		9,080 2.45 €22,246
2026-08-11 2026-08-06 S Sale
Marver D.L.

CEO
2,845
2.45
€6,970 		2,845 2.45 €6,970
2026-08-07 2026-08-06 S Sale
3.3
D.L. Marver
Director or Supervisory Board Member
15,188
2.45
€37,211 		15,188 2.45 €37,211
2026-08-11 2026-08-05 S Sale
Marver D.L.

CEO
847
2.46
€2,084 		847 2.46 €2,084
2026-08-07 2026-08-05 S Sale
3.3
D.L. Marver
Director or Supervisory Board Member
4,645
2.46
€11,427 		4,645 2.46 €11,427
2026-04-08 2026-04-02 S Sale
3.3
Marver, Lawrence

CEO
152,759
3.27
€499,522 		152,759 3.27 €499,522
2024-03-25 2024-03-25 B Purchase
I. Curtis
Director or Supervisory Board Member
111,089
4.50
€499,900 		111,089 4.50 €499,900
2024-03-25 2024-03-25 B Purchase
K.M. Dziekan
Director or Supervisory Board Member
22,222
4.50
€99,999 		22,222 4.50 €99,999
2024-03-25 2024-03-25 B Purchase
G.R. Courtine
Director or Supervisory Board Member
22,222
4.50
€99,999 		22,222 4.50 €99,999
2024-03-25 2024-03-25 B Purchase
F.A. Colen
Director or Supervisory Board Member
22,222
4.50
€99,999 		22,222 4.50 €99,999
2024-03-25 2024-03-25 B Purchase D.L. Marver Director or Supervisory Board Member
33,245
4.50
€149,602 		33,245 4.50 €149,602
Explore more

More insider trading research around ONWARD Medical NV

More insider trades in Netherlands
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in Europe